drugset / Trial / NCT05333744
The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy
RandomizedParallel-groupOpen-labelTreatment
Summary
Randomized, open-label study to compare the efficacy and safety of prednisone plus recombinant human thrombopoietin (rhTPO) compared to prednisone monotherapy for the treatment of immune thrombocytopenia in pregnancy
Timeline
- Start
- 2021-06-01
- Primary completion
- 2022-06-01
- Completion
- 2022-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | recombinant human thrombopoietin | Protein / enzyme biologic | 300 iu/kg | Intramuscular |
| Background | Prednisone | Other / unclassified | 5 mg | Oral |
| Background | Prednisone | Other / unclassified | 10 mg | Oral |